These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2130004)

  • 1. Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin.
    Gould IM; Milne K; Jason C
    Drugs Exp Clin Res; 1990; 16(12):621-8. PubMed ID: 2130004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-antibiotic effect induced by an antibiotic combination: influence of altered susceptibility to individual components.
    Li RC; Tang MC
    J Antimicrob Chemother; 2005 Apr; 55(4):583-6. PubMed ID: 15728143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of Scandinavian in vitro studies with ciprofloxacin.
    Forsgren A
    Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.
    Owen RJ; Li J; Nation RL; Spelman D
    J Antimicrob Chemother; 2007 Mar; 59(3):473-7. PubMed ID: 17289768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The postantibiotic effect.
    Spivey JM
    Clin Pharm; 1992 Oct; 11(10):865-75. PubMed ID: 1341993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
    Zuccarelli M; Simeon de Buochberg M; Maillols H; Dusart G; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):410-3. PubMed ID: 3136423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination effect of ciprofloxacin and gentamicin against clinical isolates of Salmonella enterica serovar typhi with reduced susceptibility to ciprofloxacin.
    Mandal S; Mandal MD; Pal NK
    Jpn J Infect Dis; 2003 Aug; 56(4):156-7. PubMed ID: 14583638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro bactericidal activity and post-antibiotic effect of dactimicin, a new aminoglycoside, alone and in combination with other antibiotics.
    Debbia EA; Schito GC; Stefani S; Nicoletti G
    Drugs Exp Clin Res; 1989; 15(3):125-8. PubMed ID: 2752911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.
    Piccolomini R; Di Girolamo A; Iacone A; Fioritoni G; Cellini L; Nicoletti M; D'Antonio D
    Drugs Exp Clin Res; 1991; 17(9):455-60. PubMed ID: 1822439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
    Chang PC; Li HY; Tang HJ; Liu JW; Wang JJ; Chuang YC
    J Microbiol Immunol Infect; 2007 Feb; 40(1):56-61. PubMed ID: 17332908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-antibiotic effect of imipenem, amikacin and ciprofloxacin against various strains of Serratia marcescens].
    Bollet C; Mallet MN; Bouchemal H; de Micco P
    Pathol Biol (Paris); 1990 May; 38(5):446-9. PubMed ID: 2195454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
    Kayser FH; Novak J
    Am J Med; 1987 Apr; 82(4A):33-9. PubMed ID: 3555058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model.
    Zelenitsky SA; Iacovides H; Harding GK; Ariano RE
    Diagn Microbiol Infect Dis; 2004 May; 49(1):67-70. PubMed ID: 15135504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM).
    Schafer JA; Hovde LB; Rotschafer JC
    J Antimicrob Chemother; 2006 Jul; 58(1):108-11. PubMed ID: 16735429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic model-based combination therapy approach to target antibiotic resistant populations emerged from ciprofloxacin exposure.
    Wu B; Derendorf H
    Pharmazie; 2010 Jun; 65(6):417-20. PubMed ID: 20614689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacodynamic parameters of gentamicin and its effect on the surface hydrophobicity of Acinetobacter baumannii].
    Hostacká A
    Ceska Slov Farm; 2000 Jan; 49(1):41-4. PubMed ID: 10953442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.